Jazz Pharmaceuticals JAZZ FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's FX effect on cash?
- Jazz Pharmaceuticals (JAZZ) reported FX effect on cash of -$400K in Q1 2026.
- How has Jazz Pharmaceuticals's FX effect on cash changed year-over-year?
- Jazz Pharmaceuticals's FX effect on cash decreased by 123.5% year-over-year, from $1.7M to -$400K.
- What is the long-term trend for Jazz Pharmaceuticals's FX effect on cash?
- Over 2 years (2023 to 2025), Jazz Pharmaceuticals's FX effect on cash has grown at a 140.1% compound annual growth rate (CAGR), from $1.14M to $6.56M.
- What does FX effect on cash mean?
- The change in cash value caused by shifting foreign exchange rates.
- How do you interpret FX effect on cash?
- A positive value indicates a favorable currency movement, while a negative value indicates an unfavorable impact on cash holdings.
- How does FX effect on cash compare across companies?
- Standard for multinational corporations; highly dependent on the geographic footprint of operations.